August 29, 2020
Emerging Treatments for Low-Risk MDS
Emerging Treatments for Low-Risk MDS
This webinar will provide an overview on low-risk MDS focusing on strategies for patient management. Details on the various approaches to treatment including new promising clinical trials and answers to concerns of patients will be discussed.
Speaker
BS
Barry Skikne, MD, FACP, FCP
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, and Acceleron for supporting this initiative.
